Incorporating isatuximab in the treatment of multiple myeloma

Lancet. 2019 Dec 7;394(10214):2045-2047. doi: 10.1016/S0140-6736(19)32684-4. Epub 2019 Nov 14.

Author

Suzanne Trudel¹

Affiliation

¹ Princess Margaret Cancer Centre, Toronto, ON M5G 1Z5, Canada. Electronic address: suzanne.trudel@uhn.ca.

PMID: 31735559
DOI: 10.1016/S0140-6736(19)32684-4

No abstract available

Publication types

Comment

MeSH terms

Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
Dexamethasone
Humans
Multiple Myeloma*
Thalidomide / analogs & derivatives

Substances

Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
Thalidomide
Dexamethasone
pomalidomide
isatuximab